Hemispherx appoints Peter Rodino to board
This article was originally published in Scrip
Executive Summary
Phailadelphia, US-based specialty pharma company Hemispherx Biopharma has appointed Peter W Rodino a director of the company following the resignation of Richard C Piani due to health reasons. Mr Rodino is president of Rodino Consulting and previously served as chair and CEO of Crossroads Health Plan.